Objective: We systematically reviewed the performance of 2010 WHO immunologic and
clinical criteria for predicting virologic failure in HIV-infected patients on antiretroviral therapy …

Background Good patient adherence to antiretroviral (ART) medication determines effective
HIV viral suppression, and thus reduces the risk of progression and transmission of HIV …

Background Low haemoglobin concentrations may be predictive of incident tuberculosis
(TB) and death in HIV-infected patients receiving antiretroviral therapy (ART), but data are …

Background Anaemia is frequently associated with both HIV-infection and HIV-related
tuberculosis (TB) in antiretroviral therapy (ART)-naïve patients in sub-Saharan Africa and is …

Background Access to antiretroviral therapy (ART) in Ethiopia has been scaled up since the
introduction of the service in 2003. Free ART was launched in 2005, resulting in fewer new …

Background & objective: Human Immunodeficiency Virus (HIV) remains one of the world's
most serious health challenges. The development of therapeutic regimens has significantly …

Background Depression and alcohol use disorder have been shown to be associated with
poor adherence to antiretroviral therapy (ART). Studies examining their association with viral …

Objectives WHO recommends HIV viral load (VL) testing 6 months after antiretroviral therapy
(ART) initiation and every 12 months thereafter, but cost prohibits routine, universal VL …

Given the detrimental effects of HIV-associated anemia on morbidity, we determined factors
associated with anemia after 96 weeks of antiretroviral therapy (ART) across age groups. An …

Background Pruritic papular eruption (PPE) of HIV is common in HIV‐infected populations
living in the tropics. Its aetiology has been attributed to insect bite reactions and it is reported …